|
1
|
Sadagurski M and White MF: Integrating
metabolism and longevity through insulin and IGF1 signaling.
Endocrinol Metab Clin North Am. 42:127–148. 2013.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Werner H: The IGF1 signaling pathway: From
basic concepts to therapeutic opportunities. Int J Mol Sci.
24(14882)2023.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Majumder P, Roy K, Bagh S and Mukhopadhyay
D: Receptor tyrosine kinases (RTKs) consociate in regulatory
clusters in Alzheimer's disease and type 2 diabetes. Mol Cell
Biochem. 459:171–182. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Muddapu VR, Dharshini SAP, Chakravarthy VS
and Gromiha MM: Neurodegenerative diseases-is metabolic deficiency
the root cause? Front Neurosci. 14(213)2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Paulson H and Shakkottai V:
Spinocerebellar ataxia type 3. In: GeneReviews®
[Internet]. Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE and
Amemiya A (eds.), Seattle (WA): University of Washington, Seattle,
1993.
|
|
6
|
Chen Y, Jin Y, Hu Z, Qiu M, Li D, Cai Q,
Tao C, Lou D, Qi L, Chen S, et al: Association between serum
neurofilament light chain and neurochemistry deficits in patients
with spinocerebellar ataxia type 3. Cerebellum. 23:92–100.
2024.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Wilke C, Haas E, Reetz K, Faber J,
Garcia-Moreno H, Santana MM, van de Warrenburg B, Hengel H, Lima M,
Filla A, et al: Neurofilaments in spinocerebellar ataxia type 3:
Blood biomarkers at the preataxic and ataxic stage in humans and
mice. EMBO Mol Med. 12(e11803)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Saute JAM, da Silva ACF, Muller AP, Hansel
G, de Mello AS, Maeda F, Vedolin L, Saraiva-Pereira ML, Souza DO,
Arpa J, et al: Serum insulin-like system alterations in patients
with spinocerebellar ataxia type 3. Mov Disord. 26:731–735.
2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Torres-Aleman I, Barrios V, Lledo A and
Berciano J: The insulin-like growth factor I system in cerebellar
degeneration. Ann Neurol. 39:335–342. 1996.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Crosby S, Tsigos C, Anderton C, Gordon C,
Young R and White A: Elevated plasma insulin-like growth factor
binding protein-1 levels in type 1 (insulin-dependent) diabetic
patients with peripheral neuropathy. Diabetologia. 35:868–872.
1992.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Busiguina S, Fernandez AM, Barrios V,
Clark R, Tolbert DL, Berciano J and Torres-Aleman I:
Neurodegeneration is associated to changes in serum insulin-like
growth factors. Neurobiol Dis. 7:657–665. 2000.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Lang CH and Frost RA: Role of growth
hormone, insulin-like growth factor-I, and insulin-like growth
factor binding proteins in the catabolic response to injury and
infection. Curr Opin Clin Nutr Metab Care. 5:271–279.
2002.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wu S, Liu K, Cheng W, Su S, Lin Y, Lin T,
Cheng Y, Chang J, Wu Y and Liu C: Growth hormone rescue cerebellar
degeneration in SCA3 transgenic mice. Biochem Biophys Res Commun.
529:467–473. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Arpa J, Sanz-Gallego I, Medina-Báez J,
Portela LV, Jardim LB, Torres-Aleman I and Saute JA: Subcutaneous
insulin-like growth factor-1 treatment in spinocerebellar ataxias:
An open label clinical trial. Mov Disord. 26:358–359.
2011.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Lin YS, Cheng WL, Chang JC, Lin TT, Chao
YC and Liu CS: IGF-1 as a potential therapy for spinocerebellar
ataxia type 3. Biomedicines. 10(505)2022.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Schmitz-Hübsch T, du Montcel ST, Baliko L,
Berciano J, Boesch S, Depondt C, Giunti P, Globas C, Infante J,
Kang JS, et al: Scale for the assessment and rating of ataxia:
Development of a new clinical scale. Neurology. 66:1717–1720.
2006.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Yang JS, Chen PP, Lin MT, Qian MZ, Lin HX,
Chen XP, Shang XJ, Wang DN, Chen YC, Jiang B, et al: Association
between body mass index and disease severity in Chinese
spinocerebellar ataxia type 3 patients. Cerebellum. 17:494–498.
2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Alehagen U, Johansson P, Aaseth J,
Alexander J and Brismar K: Increase in insulin-like growth factor 1
(IGF-1) and insulin-like growth factor binding protein 1 after
supplementation with selenium and coenzyme Q10. A prospective
randomized double-blind placebo-controlled trial among elderly
Swedish citizens. PLoS One. 12(e0178614)2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhou J, Lei L, Liao X, Wang J, Jiang H,
Tang B and Shen L: Related factors of ICARS and SARA scores on
spinocerebellar ataxia type 3/Machado-Joseph disease. Zhong Nan Da
Xue Xue Bao Yi Xue Ban. 36:498–503. 2011.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Li QF, Dong Y, Yang L, Xie JJ, Ma Y, Du
YC, Cheng HL, Ni W and Wu ZY: Neurofilament light chain is a
promising serum biomarker in spinocerebellar ataxia type 3. Mol
Neurodegener. 14(39)2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Maas RPPWM, van Gaalen J, Klockgether T
and van de Warrenburg BPC: The preclinical stage of spinocerebellar
ataxias. Neurology. 85:96–103. 2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Hancox RJ and Landhuis CE: Correlation
between measures of insulin resistance in fasting and non-fasting
blood. Diabetol Metab Syndr. 3(23)2011.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Chiu C, Cheng W, Lin Y, Lin T, Chang H,
Chang Y, Lee C, Chang H and Liu C: A pilot study: Handgrip as a
predictor in the disease progression of SCA3. Orphanet J Rare Dis.
18(317)2023.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Levy JC, Matthews DR and Hermans MP:
Correct homeostasis model assessment (HOMA) evaluation uses the
computer program. Diabetes Care. 21:2191–2192. 1998.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Katz A, Nambi SS, Mather K, Baron AD,
Follmann DA, Sullivan G and Quon MJ: Quantitative insulin
sensitivity check index: A simple, accurate method for assessing
insulin sensitivity in humans. J Clin Endocrinol Metab.
85:2402–2410. 2000.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Molina-Castro M, Rowitz B and Pepino MY:
Glucagon-like peptide-1, fibroblast growth factor 21, and other
endocrine responses to alcohol ingestion in women before and after
metabolic surgery. Front Pharmacol. 16(1575156)2025.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Rajaram S, Baylink DJ and Mohan S:
Insulin-like growth factor-binding proteins in serum and other
biological fluids: Regulation and functions. Endocr Rev.
18:801–831. 1997.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Lee PD, Conover CA and Powell DR:
Regulation and function of insulin-like growth factor-binding
protein-1. Proc Soc Exp Biol Med. 204:4–29. 1993.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Bunn RC, King WD, Winkler MK and Fowlkes
JL: Early developmental changes in IGF-I, IGF-II, IGF binding
protein-1, and IGF binding protein-3 concentration in the
cerebrospinal fluid of children. Pediatr Res. 58:89–93.
2005.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Lewitt MS and Boyd GW: The role of
insulin-like growth factors and insulin-like growth factor-binding
proteins in the nervous system. Biochem Insights.
12(1178626419842176)2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Ramani B, Panwar B, Moore LR, Wang B,
Huang R, Guan Y and Paulson HL: Comparison of spinocerebellar
ataxia type 3 mouse models identifies early gain-of-function,
cell-autonomous transcriptional changes in oligodendrocytes. Hum
Mol Genet. 26:3362–3374. 2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Schuster KH, Zalon AJ, Zhang H, DiFranco
DM, Stec NR, Haque Z, Blumenstein KG, Pierce AM, Guan Y, Paulson HL
and McLoughlin HS: Impaired oligodendrocyte maturation is an early
feature in SCA3 disease pathogenesis. J Neurosci. 42:1604–1617.
2022.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Evert BO, Vogt IR, Vieira-Saecker AM,
Ozimek L, de Vos RA, Brunt ER, Klockgether T and Wüllner U: Gene
expression profiling in ataxin-3 expressing cell lines reveals
distinct effects of normal and mutant ataxin-3. J Neuropathol Exp
Neurol. 62:1006–1018. 2003.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Nolte AA, Movin M, Lundin H and Salminen
H: IGFBP-1 predicts all-cause mortality in elderly women
independently of IGF-I. Growth Horm IGF Res. 25:281–285.
2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Leite CMBA, Schieferdecker MEM, Frehner C,
Munhoz RP, Ashizawa T and Teive HAG: Body composition in
Spinocerebellar ataxia type 3 and 10 patients: Comparative study
with control group. Nutr Neurosci. 23:49–54. 2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Ye P, Carson J and D'Ercole AJ: In vivo
actions of insulin-like growth factor-I (IGF-I) on brain
myelination: Studies of IGF-I and IGF binding protein-1 (IGFBP-1)
transgenic mice. J Neurosci. 15:7344–7356. 1995.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Biadgo B, Tamir W and Ambachew S:
Insulin-like growth factor and its therapeutic potential for
diabetes complications-mechanisms and metabolic links: A review.
Rev Diabet Stud. 16:24–34. 2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Arcos J, Grunenwald F, Sepulveda D, Jerez
C, Urbina V, Huerta T, Troncoso-Escudero P, Tirado D, Perez A,
Diaz-Espinoza R, et al: IGF2 prevents dopaminergic neuronal loss
and decreases intracellular alpha-synuclein accumulation in
Parkinson's disease models. Cell Death Discov.
9(438)2023.PubMed/NCBI View Article : Google Scholar
|
|
39
|
García-Huerta P, Troncoso-Escudero P, Wu
D, Thiruvalluvan A, Cisternas-Olmedo M, Henríquez DR, Plate L,
Chana-Cuevas P, Saquel C, Thielen P, et al: Insulin-like growth
factor 2 (IGF2) protects against Huntington's disease through the
extracellular disposal of protein aggregates. Acta Neuropathol.
140:737–764. 2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Coarelli G, Darios F, Petit E, Dorgham K,
Adanyeguh I, Petit E, Brice A, Mochel F and Durr A: Plasma
neurofilament light chain predicts cerebellar atrophy and clinical
progression in spinocerebellar ataxia. Neurobiol Dis.
153(105311)2021.PubMed/NCBI View Article : Google Scholar
|
